Patients with myelodysplastic syndrome (MDS) are at risk of relapse after allogeneic hematopoietic cell transplantation. The utility of ultra-deep genomic testing to predict and the impact of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results